Changing treatment patterns for coronary artery revascularization in Canada: the projected impact of drug eluting stents
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2261
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Changing treatment patterns for coronary artery revascularization in Canada: the projected impact of drug eluting stents ; volume:4 ; number:1 ; day:13 ; month:12 ; year:2004 ; pages:1-9 ; date:12.2004
BMC cardiovascular disorders ; 4, Heft 1 (13.12.2004), 1-9, 12.2004
- Creator
-
Halpern, Michael T.
- Contributor
-
Lacey, Michael
Clark, Mary Ann
Valentin, Miguel A.
SpringerLink (Online service)
- DOI
-
10.1186/1471-2261-4-23
- URN
-
urn:nbn:de:1111-2016030244552
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:25 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Halpern, Michael T.
- Lacey, Michael
- Clark, Mary Ann
- Valentin, Miguel A.
- SpringerLink (Online service)
Other Objects (12)
A meta-analysis of everolimus-eluting stents versus sirolimus-eluting stents and paclitaxel-eluting stents in diabetic patients
Biodegradable polymer everolimus-eluting stents versus contemporary drug-eluting stents: a systematic review and meta‑analysis
Two-Year Follow-up of Sirolimus-Eluting Stents versus Paclitaxel-Eluting Stents in Acute Myocardial Infarction
Drug-coated balloon-based versus drug-eluting stent-only revascularization in patients with diabetes and multivessel coronary artery disease
Case series of coronary artery aneurysms after Everolimus eluting stent implantation and comparison with Sirolimus eluting stents
Risk factors for revascularization and in-stent restenosis in patients with triple-vessel disease after second-generation drug-eluting stent implantation: a retrospective analysis
Clinical outcome of biodegradable polymer sirolimus-eluting stent and durable polymer everolimus-eluting stent in patients with diabetes
Lebensqualitätsentwicklung nach Implantation von drug eluting stents im Vergleich zu bare metal stents : eine Analyse des Deutschen Drug Eluting Stent-Registers (DES.DE)
Clinical Outcome of Paclitaxel-Coated Balloon Angioplasty Versus Drug-Eluting Stent Implantation for the Treatment of Coronary Drug-Eluting Stent In-Stent Chronic Total Occlusion
Comparison of the safety and efficacy of biodegradable polymer drug-eluting stents versus durable polymer drug-eluting stents: a meta-analysis
Inzidenz und Prädiktoren der Stentthrombose in Bare-Metal-Stents und Drug-Eluting-Stents
Drug Eluting Stents in der Therapie von chronischen Koronarverschlüssen
A meta-analysis of everolimus-eluting stents versus sirolimus-eluting stents and paclitaxel-eluting stents in diabetic patients
Biodegradable polymer everolimus-eluting stents versus contemporary drug-eluting stents: a systematic review and meta‑analysis
Two-Year Follow-up of Sirolimus-Eluting Stents versus Paclitaxel-Eluting Stents in Acute Myocardial Infarction
Drug-coated balloon-based versus drug-eluting stent-only revascularization in patients with diabetes and multivessel coronary artery disease
Case series of coronary artery aneurysms after Everolimus eluting stent implantation and comparison with Sirolimus eluting stents
Risk factors for revascularization and in-stent restenosis in patients with triple-vessel disease after second-generation drug-eluting stent implantation: a retrospective analysis
Clinical outcome of biodegradable polymer sirolimus-eluting stent and durable polymer everolimus-eluting stent in patients with diabetes
Lebensqualitätsentwicklung nach Implantation von drug eluting stents im Vergleich zu bare metal stents : eine Analyse des Deutschen Drug Eluting Stent-Registers (DES.DE)
Clinical Outcome of Paclitaxel-Coated Balloon Angioplasty Versus Drug-Eluting Stent Implantation for the Treatment of Coronary Drug-Eluting Stent In-Stent Chronic Total Occlusion
Comparison of the safety and efficacy of biodegradable polymer drug-eluting stents versus durable polymer drug-eluting stents: a meta-analysis
Inzidenz und Prädiktoren der Stentthrombose in Bare-Metal-Stents und Drug-Eluting-Stents
Drug Eluting Stents in der Therapie von chronischen Koronarverschlüssen
A meta-analysis of everolimus-eluting stents versus sirolimus-eluting stents and paclitaxel-eluting stents in diabetic patients
Biodegradable polymer everolimus-eluting stents versus contemporary drug-eluting stents: a systematic review and meta‑analysis
Two-Year Follow-up of Sirolimus-Eluting Stents versus Paclitaxel-Eluting Stents in Acute Myocardial Infarction
Drug-coated balloon-based versus drug-eluting stent-only revascularization in patients with diabetes and multivessel coronary artery disease
Case series of coronary artery aneurysms after Everolimus eluting stent implantation and comparison with Sirolimus eluting stents
Risk factors for revascularization and in-stent restenosis in patients with triple-vessel disease after second-generation drug-eluting stent implantation: a retrospective analysis
Clinical outcome of biodegradable polymer sirolimus-eluting stent and durable polymer everolimus-eluting stent in patients with diabetes
Lebensqualitätsentwicklung nach Implantation von drug eluting stents im Vergleich zu bare metal stents : eine Analyse des Deutschen Drug Eluting Stent-Registers (DES.DE)
Clinical Outcome of Paclitaxel-Coated Balloon Angioplasty Versus Drug-Eluting Stent Implantation for the Treatment of Coronary Drug-Eluting Stent In-Stent Chronic Total Occlusion
Comparison of the safety and efficacy of biodegradable polymer drug-eluting stents versus durable polymer drug-eluting stents: a meta-analysis
Inzidenz und Prädiktoren der Stentthrombose in Bare-Metal-Stents und Drug-Eluting-Stents